Yunzheng Li

机构：Nanjing University of Chinese Medicine, Nanjing Drum Tower Hospital, Xi'an Jiaotong University · ORCID：0000-0002-4541-1909

发表论文 68 篇 · 总被引 927 次 · h-index 14

代表论文

Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma (2023 · Hepatology · 被引 102)
β-Catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma (2024 · Cancer Research · 被引 29)
TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma (2024 · Oncogene · 被引 26)
Apolipoprotein A1-encoding recombinant adenovirus remodels cholesterol metabolism in tumors and the tumor microenvironment to inhibit hepatocellular carcinoma (2024 · Translational research · 被引 13)
Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function (2023 · Cell Death and Differentiation · 被引 12)
HOXA9 promotes proliferation, metastasis and prevents apoptosis in hepatocellular carcinoma (2024 · Journal of Cancer Research and Clinical Oncology · 被引 7)